Cancer-killing cells controlled by epigenetic process, new study shows

By Alison Trinidad

Natural killer (NK) cells in the human body can kill and contain viruses and cancerous tumors. A new study from the Keck School of Medicine of USC describes for the first time how those cells can be manipulated by epigenetics. The discovery, detailed in the Proceedings of the National Academy of Sciences, paves the way for developing more effective cancer drugs. Read More »

October 18th, 2013|Announcements|

USC team given new grant to study genetic makeup underlying disease risks in minority populations

By Leslie Ridgeway

A research team co-led by USC Norris Comprehensive Cancer Center scientists is one of five teams to be awarded four-year grants totaling nearly $14 million to study the genomics of disease susceptibility in ethnically diverse populations. The National Institutes of Health (NIH) awarded the grant funds.

A team led by co-principal investigators Christopher Haiman, PhD, professor of preventive medicine, Keck School of Medicine of USC, and Loic Le Marchand, MD, PhD of the University of Hawaii, Honolulu, is scheduled to be awarded $3.1 million to examine the DNA from samples collected from the Multiethnic Cohort (MEC). Read More »

October 18th, 2013|Announcements|

Physician Assistant students receive 100 percent pass rate on national certifying exam

By Elise Herrera-Green

The class of 2013 of the Physician Assistant Program at USC, comprised of 50 graduates, received a 100 percent pass rate for first-time test takers on the National Commission on Certification of Physician Assistants (NCCPA) Physician Assistant National Certifying Exam (PANCE). Read More »

October 18th, 2013|Announcements|

USC scientists ID protein that regulates cellular trafficking, potential for anti-cancer therapy

By Alison Trinidad

Chengyu Liang, MD, PhD, was the principal investigator on a new study that discovered two intracellular processes that could lead to novel therapeutics for cancer treatment. Chengyu Liang, MD, PhD, was the principal investigator on a new study that discovered two intracellular processes that could lead to novel therapeutics for cancer treatment.

Molecular microbiologists at the Keck School of Medicine of USC have uncovered intricate regulatory mechanisms within the cell that could lead to novel therapeutics for the treatment of cancer and other diseases. Their findings, which have long-standing significance in the basic understanding of cell biology, appear in the journal Nature Cell Biology.

“Our research reveals a new regulatory mechanism that coordinates two distinct intracellular processes that are critical to cellular homeostasis and disease development,” said Chengyu Liang, MD, PhD, assistant professor of molecular microbiology and immunology at the Keck School and principal investigator of the study. Read More »

October 18th, 2013|Announcements|

Keck School student receives NAMME scholarship

By Elise Herrera-Green

Sheila Lau, a second-year student in the Keck School of Medicine of USC’s Primary Care Physician Assistant Program, has been selected to receive a 2013 National Association of Medical Minority Educators (NAMME) Scholarship. Lau was one of only eight students in the nation selected for this scholarship. Read More »

October 18th, 2013|Announcements|